1. Home
  2. IMNM vs CWK Comparison

IMNM vs CWK Comparison

Compare IMNM & CWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$19.35

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo Cushman & Wakefield plc

CWK

Cushman & Wakefield plc

HOLD

Current Price

$13.00

Market Cap

3.1B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMNM
CWK
Founded
2006
1784
Country
United States
United States
Employees
N/A
53000
Industry
Medicinal Chemicals and Botanical Products
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
3.1B
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
IMNM
CWK
Price
$19.35
$13.00
Analyst Decision
Strong Buy
Buy
Analyst Count
10
7
Target Price
$32.80
$17.64
AVG Volume (30 Days)
1.3M
1.9M
Earning Date
05-08-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
51.40
N/A
EPS
N/A
N/A
Revenue
$6,941,000.00
$10,288,200,000.00
Revenue This Year
N/A
$6.87
Revenue Next Year
$1,127.34
$5.98
P/E Ratio
N/A
N/A
Revenue Growth
N/A
8.91
52 Week Low
$7.96
$10.94
52 Week High
$27.65
$17.40

Technical Indicators

Market Signals
Indicator
IMNM
CWK
Relative Strength Index (RSI) 46.93 49.56
Support Level $19.28 $11.78
Resistance Level $23.00 $14.22
Average True Range (ATR) 0.84 0.51
MACD 0.21 -0.01
Stochastic Oscillator 49.16 29.10

Price Performance

Historical Comparison
IMNM
CWK

About IMNM Immunome Inc.

Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.

About CWK Cushman & Wakefield plc

Cushman & Wakefield is one of the largest commercial real estate services firms in the world and is headquartered in Chicago. The firm provides a broad suite of real estate-related services to owners, tenants, and investors. These include brokerage services for leasing and capital markets sales as well as advisory services such as valuation, project management, and facilities management.

Share on Social Networks: